Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice? - Wikidata - awgldk - TriplyDB

Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?

Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?

http://www.wikidata.org/entity/Q38423493

about

Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?

P2860

Q47109397-241EF258-5A8A-4413-A4E5-4E36093895BD

P2860

Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?

http://www.wikidata.org/entity/Q38423493

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?

@en

type

label

Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?

@en

prefLabel

Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?

@en

P1433

Q38423493-8BEAAE9D-3845-4185-923E-17E91664CD1A

P1476

Q38423493-22CADADD-7EAF-4257-8E6A-F14014ECC788

P2093

Q38423493-33A4980C-5AE1-4C69-BA05-4FF88B4F2351

Q38423493-4EA361C5-477E-40C0-9D36-0B47634AC994

Q38423493-6F6346F2-9F73-4E1D-A236-92185025F769

Q38423493-7C0C4121-742B-471C-87F7-04F36AE4E1D2

P2860

Q38423493-0284EEA0-AE05-4BA0-ACC0-4B55467A7238

Q38423493-070C31E8-5F11-4376-8566-33910C0533FB

Q38423493-08E2DF77-6226-4DB4-885A-A9E01116C624

Q38423493-167909A0-85A6-4C4B-8415-003276150859

Q38423493-1EC06E93-60CD-40D9-B6F6-5A114A64B2BD

Q38423493-22CA69A9-0BB0-4893-916A-5FE52179A01A

Q38423493-2319306E-1363-4AEE-A419-491FFADB07FB

Q38423493-26279DBD-904B-4336-B04B-997C855BD000

Q38423493-3B408F08-CB7B-4323-BF71-F63C63AE8332

Q38423493-4423DE24-CEAC-4CA3-9CB5-6828CBC20DA6

P304

Q38423493-1E663A8A-83E0-4A60-80AD-B17335A38D80

P31

Q38423493-3F031C83-07AA-4878-B340-C556516C4464

P356

Q38423493-3AC5A75D-7881-442E-8A37-A8970BAC6B47

P433

Q38423493-226FA8B9-899D-4836-8965-1A8BE241A7F3

P478

Q38423493-20190748-2C7E-45DE-9E95-198B22482447

P50

Q38423493-7D0676EC-2E63-4C35-A40D-427DAE540B09

P577

Q38423493-C739D5C0-A016-482B-A70E-C9A2091408EE

P698

Q38423493-4EFCDA83-8D9C-42C8-AE69-7523CB324AE1

P921

Q38423493-290CA7DB-5BFD-49F5-8265-5D178A056A96

P356

1755-5922.12124

P1433

Cardiovascular Therapeutics

P1476

Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?

@en

P2093

Ahmed Abuzaid

http://www.w3.org/2001/XMLSchema#string

Ahmed Mahmoud

http://www.w3.org/2001/XMLSchema#string

Islam Y Elgendy

http://www.w3.org/2001/XMLSchema#string

Marwan Saad

http://www.w3.org/2001/XMLSchema#string

P2860

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Bivalirudin for patients with acute coronary syndromes

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Bivalirudin during primary PCI in acute myocardial infarction

Pharmacology and clinical use of bivalirudin.

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

Bivalirudin: pharmacology and clinical applications.

Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.

P304

227-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1755-5922.12124

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Islam Y. Elgendy

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25879426

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation